Posted on November 20th, 2008 by Health News
Tissue Genesis, Inc., an innovator of advanced tissue engineering and cell therapy solutions, today announced that effective immediately, the Tissue Genesis Cell Isolation System will be available to the European marketplace.
Read more
Filed under: Pharmacy News
Tags: gene, Pharmacy
Related posts
- Wyeth and Santaris Pharma to collaborate on RNA-based medicines (0)
Wyeth Pharmaceuticals, a division of Wyeth, and Santaris Pharma have announced that the companies have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines based on Santaris Pharma's proprietary Locked Nucleic Acid (LNA) drug platform, which allows specific targeting and regulation of microRNAs (miRNAs) and messenger RNAs (mRNAs) as a means [...]
- World Gene Therapy Market To Reach $484 Million By 2015 (0)
Advancements in gene therapy have provided useful data, which has helped in understanding the pathogenesis of diseases. The discipline heralds a significant potential for the biotechnology industry over the next 20 years, as the approach moves from research labs to clinical trials.
Read more
[tags] Pharmacy News [/tags]
- VTT to develop next-generation vaccines against allergy (0)
VTT holds patents on gene technology which can be applied to alter the structure of an allergen, i.e. a protein causing allergy, so that it will cause less allergic symptoms than the original allergen, while remaining effective in desensitisation therapy.
Read more
[tags] Pharmacy News [/tags]
- Vorinostat in addition to chemotherapy drugs improves remission rates in AML patients (0)
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.
Read more
[tags] Pharmacy News [/tags]
- VIRxSYS Publishes New Study On RNA Therapy (0)
VIRxSYS Corporation announced the publication of a new research article, "Trans-splicing into Highly Abundant Albumin Transcripts for Production of Therapeutic Proteins In Vivo," in the journal Molecular Therapy. The study describes a novel RNA therapy technique in which an RNA molecule that is inserted into the albumin gene "hijacks" the albumin, causing it to [...]
Leave a Reply